Peter Rossi, MD

Associate Professor and Medical Director

Department of Radiation Oncology

James C. Kennedy Chair in Prostate Cancer

Winship Cancer Institute of Emory University


Phone:

(678) 843-7004

Location:

Winship at Emory Saint Joseph's Hospital

Directions

Biography

Peter Rossi, MD, is a board certified radiation oncologist in the Department of Radiation Oncology at Emory University School of Medicine in Atlanta, GA. Dr. Rossi practices general radiation oncology and specializes in the treatment of prostate cancer as well as testicular cancer, gynecologic, gastrointestinal and thoracic malignancies. He treats patients at Emory Saint Joseph's Hospital where he serves as Medical Director.

Dr. Rossi's expertise is in the use of external radiation therapy and brachytherapy for treating tumors of the genitourinary tract and gynecological organs. He holds joint appointments in the Department of Urology and Radiation Oncology at the Emory University School of Medicine. Dr. Rossi was named an endowed chair through a $25 million gift from the James M. Cox Foundation to lead a new patient-centered care initiative at Winship Cancer Institute and Emory University. Dr. Rossi lives near Emory's campus with his wife, Mila, and their two children.

Education

Dr. Rossi received his MD at Wayne State University School of Medicine in Detroit, Michigan. He completed an internship in general surgery at Naval Medical Center in San Diego. He served as a general medical officer and Lieutenant Commander in the United States Navy, completing overseas and stateside appointments. He completed his residency in radiation oncology at Wake Forest University in North Carolina, where he trained in Gamma Knife radiosurgery and served as chief resident. He also earned a fellowship from the American Brachytherapy Society and received special training in brachytherapy at the Seattle Prostate Institute.

Awards

Dr. Rossi's society memberships include the American Medical Association, the American Radium Society, and the American Society of Therapeutic Radiation and Oncology. In addition to his clinical work, Dr. Rossi is a leader in cancer education and research. He lectures about advances in prostate cancer and gynecological cancers at regional tumor boards, assists in establishing the curriculum for the education of the treatment of these tumors for national meetings, and helps establish models for physician quality review of practices.

Dr. Rossi was first in Georgia to utilize Calypso medical technology, a system to localize and track prostate motion during external radiation treatments for prostate cancer to better "find" the cancer and minimize the side effect from radiation exposure to adjacent critical organs. He was also first to treat prostate cancer using Rapid Arc technology combined with Calypso medical technologies.

Dr. Rossi was the recipient of the 2013 Atlanta Magazine Groundbreakers Innovation Award.

Research

Dr. Rossi's research interests are focused on improving the outcomes for genitourinary and gynecologic malignancies. As an academic physician involved in clinical trials to advance practice standards, Dr. Rossi teaches fellows, residents and medical students, and directs patient care.

Dr. Rossi is principal investigator for institutional and national clinical research studies to advance current care of patients with cancer. He writes questions for national board exams for radiation oncologists. He has over 60 publications in international peer reviewed journals focusing on improving treatment outcomes in prostate cancer and gynecological malignancies. He serves on editorial review boards and scientific education committees for notable radiation oncology journals and national/international radiation oncology organization.

Dr. Rossi has authored studies for novel interventions to improve the quality of life of patients receiving brachytherapy for prostate cancer or external radiation therapy for treatment of prostate cancer or gynecological malignancies. He lectures and instructs nationally on brachytherapy or seed implants for the treatment of prostate cancer.

Publications